Albert David Limited (NSE: ALBERTDAVD)

Market Cap	7.47B
Revenue (ttm)	3.65B
Net Income (ttm)	685.47M
Shares Out	n/a
EPS (ttm)	120.10
PE Ratio	10.90
Forward PE	n/a
Dividend	11.50 (0.87%)
Ex-Dividend Date	Aug 2, 2024

Volume	3,843
Open	1,308.75
Previous Close	1,308.75
Day's Range	1,304.70 - 1,338.00
52-Week Range	959.70 - 1,753.95
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 7, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,497
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In 2023, Albert David's revenue was 3.62 billion, an increase of 6.12% compared to the previous year's 3.42 billion. Earnings were 754.20 million, an increase of 108.49%.